BlueWind’s Revi urinary incontinence device demonstrates three-year efficacy
BlueWind Medical’s Revi implantable tibial neuromodulation (ITNM) system has demonstrated sustained efficacy and safety at the three-year mark in a…
BlueWind Medical’s Revi implantable tibial neuromodulation (ITNM) system has demonstrated sustained efficacy and safety at the three-year mark in a…
Roche and KlinRisk have secured CE mark approval for their AI-driven risk stratification tool, designed for evaluating the progression of…
The US Food and Drug Administration (FDA) has added haemodialysis bloodlines to its medical device shortages list amid supply disruptions.…
FemPulse is set to enter the pivotal clinical trial phase with its neuromodulation system to treat overactive bladder after the…
Baxter has issued a correction for its AK 98 haemodialysis machines, with the US Food and Drug Administration (FDA) classifying…
Following positive data reported earlier this year from a Phase I/II trial, Sequana Medical has touted results from a study…
EndoTheia has completed the clinical trial of its FlexStone Basket, an independently steerable device, designed for kidney stone removal. This…
Xeltis has hit two milestones for its vascular access conduit, with one coming in the regulatory arena and the other…
SonoMotion has received the US Food and Drug Administration (FDA) de novo clearance for its Stone Clear device, a non-invasive…
King Faisal Specialist Hospital & Research Centre (KFSHRC) in Saudi Arabia has entered a five-year partnership with the University of…